Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Natural killer cells modulation in hematological malignancies.

Baier C, Fino A, Sanchez C, Farnault L, Rihet P, Kahn-Perlès B, Costello RT.

Front Immunol. 2013 Dec 19;4:459. doi: 10.3389/fimmu.2013.00459.

2.

Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications.

Farnault L, Sanchez C, Baier C, Le Treut T, Costello RT.

Clin Dev Immunol. 2012;2012:421702. doi: 10.1155/2012/421702. Epub 2012 Aug 1. Review.

3.

NK cells: innate immunity against hematological malignancies?

Costello RT, Fauriat C, Sivori S, Marcenaro E, Olive D.

Trends Immunol. 2004 Jun;25(6):328-33. Review.

PMID:
15145323
4.

Natural killer cell-triggering receptors in patients with acute leukaemia.

Fauriat C, Marcenaro E, Sivori S, Rey J, Gastaut JA, Moretta A, Olive D, Costello RT.

Leuk Lymphoma. 2003 Oct;44(10):1683-9. Review.

PMID:
14692519
5.

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies.

Gismondi A, Stabile H, Nisti P, Santoni A.

Front Immunol. 2015 Nov 5;6:567. doi: 10.3389/fimmu.2015.00567. eCollection 2015. Review.

6.
7.

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.

Sanchez CJ, Le Treut T, Boehrer A, Knoblauch B, Imbert J, Olive D, Costello RT.

Cancer Immunol Immunother. 2011 Jan;60(1):1-13. doi: 10.1007/s00262-010-0898-x. Epub 2010 Aug 10. Review.

PMID:
20697893
8.

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.

Carrega P, Pezzino G, Queirolo P, Bonaccorsi I, Falco M, Vita G, Pende D, Misefari A, Moretta A, Mingari MC, Moretta L, Ferlazzo G.

PLoS One. 2009 Dec 4;4(12):e8132. doi: 10.1371/journal.pone.0008132.

9.

Teleost T and NK cell immunity.

Fischer U, Koppang EO, Nakanishi T.

Fish Shellfish Immunol. 2013 Aug;35(2):197-206. doi: 10.1016/j.fsi.2013.04.018. Epub 2013 May 7. Review.

PMID:
23664867
10.

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Gras Navarro A, Björklund AT, Chekenya M.

Front Immunol. 2015 Apr 29;6:202. doi: 10.3389/fimmu.2015.00202. eCollection 2015. Review.

11.

Natural killer cell immune escape in acute myeloid leukemia.

Lion E, Willemen Y, Berneman ZN, Van Tendeloo VF, Smits EL.

Leukemia. 2012 Sep;26(9):2019-26. doi: 10.1038/leu.2012.87. Epub 2012 Mar 26. Review.

PMID:
22446501
12.

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.

Campoli M, Ferrone S.

Tissue Antigens. 2008 Oct;72(4):321-34. doi: 10.1111/j.1399-0039.2008.01106.x. Epub 2008 Aug 12. Review.

13.

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.

Siegler U, Kalberer CP, Nowbakht P, Sendelov S, Meyer-Monard S, Wodnar-Filipowicz A.

Leukemia. 2005 Dec;19(12):2215-22.

PMID:
16224486
14.

The innate immune response to tumors and its role in the induction of T-cell immunity.

Diefenbach A, Raulet DH.

Immunol Rev. 2002 Oct;188:9-21. Review.

PMID:
12445277
15.

The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.

Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.

Eur J Immunol. 2003 Jun;33(6):1657-66. Erratum in: Eur J Immunol. 2003 Oct;33(10):2947.

16.

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

Algarra I, García-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F.

Cancer Immunol Immunother. 2004 Oct;53(10):904-10. Epub 2004 Apr 7. Review.

PMID:
15069585
18.

The role of natural killer cells in hematopoietic stem cell transplantation.

Tsirigotis PD, Resnick IB, Shapira MY.

Ann Med. 2012 Mar;44(2):130-45. doi: 10.3109/07853890.2011.554430. Epub 2011 Mar 17. Review.

PMID:
21410396
19.

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A.

Blood. 2011 Jan 20;117(3):764-71. doi: 10.1182/blood-2010-08-264085. Epub 2010 Oct 1. Review.

20.

RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.

Zeng XC, Zhang T, Huang DH, Wang GY, Chen W, Li H, Zhang J, Fang TL, Zhang Q, Chen GH.

Ann Clin Lab Sci. 2013 Spring;43(2):135-44.

PMID:
23694787

Supplemental Content

Support Center